Control of Expression of Key Cell Cycle Enzymes Drives Cell Line-Specific Functions of CDK7 in Human PDAC Cells
Related Experiment Video
Updated: Oct 6, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Lina Kolloch1, Teresa Kreinest1, Michael Meisterernst1
1Institute of Molecular Tumor Biology, Faculty of Medicine, University Muenster, 48149 Muenster, Germany.
Abstract:
Inhibition of the dual function cell cycle and transcription kinase CDK7 is known to affect the viability of cancer cells, but the mechanisms underlying cell line-specific growth control remain poorly understood. Here, we employed a previously developed, highly specific small molecule inhibitor that non-covalently blocks ATP binding to CDK7 (LDC4297) to study the mechanisms underlying cell line-specific growth using a panel of genetically heterogeneous human pancreatic tumor lines as model system. Although LDC4297 diminished both transcription rates and CDK T-loop phosphorylation in a comparable manner, some PDAC lines displayed significantly higher sensitivity than others. We focused our analyses on two well-responsive lines (Mia-Paca2 and Panc89) that, however, showed significant differences in their viability upon extended exposure to limiting LDC4297 concentrations. Biochemical and RNAseq analysis revealed striking differences in gene expression and cell cycle control. Especially the downregulation of a group of cell cycle control genes, among them CDK1/2 and CDC25A/C, correlated well to the observed viability differences in Panc89 versus Mia-Paca2 cells. A parallel downregulation of regulatory pathways supported the hypothesis of a feedforward programmatic effect of CDK7 inhibitors, eventually causing hypersensitivity of PDAC lines.
Insights
Targeting the cell cycle and transcription kinase CDK7 impacts cancer cell viability. This study reveals cell line-specific growth differences in pancreatic cancer cells treated with the CDK7 inhibitor LDC4297, linked to gene expression changes.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Cyclin-dependent kinase 7 (CDK7) is a dual-function kinase regulating both cell cycle progression and transcription.
- Inhibition of CDK7 affects cancer cell viability, but the precise mechanisms driving cell line-specific responses are not fully understood.
- Pancreatic ductal adenocarcinoma (PDAC) presents a significant challenge, necessitating research into novel therapeutic targets and mechanisms.
Purpose of the Study:
- To investigate the mechanisms of cell line-specific growth control in human pancreatic tumor lines using a specific CDK7 inhibitor.
- To elucidate the differential responses of PDAC cell lines to CDK7 inhibition at the molecular level.
- To identify key gene expression and cell cycle regulatory pathways affected by CDK7 inhibition in PDAC.
Main Methods:
- Utilized LDC4297, a specific small molecule inhibitor targeting ATP binding to CDK7.
- Employed a panel of genetically heterogeneous human pancreatic tumor cell lines.
- Performed biochemical analyses and RNA sequencing (RNAseq) to assess gene expression and cell cycle control.
Main Results:
- LDC4297 effectively reduced transcription rates and CDK T-loop phosphorylation across tested PDAC lines.
- Significant variations in sensitivity and viability were observed among different PDAC cell lines upon LDC4297 treatment.
- Downregulation of cell cycle control genes, including CDK1/2 and CDC25A/C, correlated with differential viability in Panc89 versus Mia-Paca2 cells.
Conclusions:
- CDK7 inhibition elicits cell line-specific responses in pancreatic cancer, mediated by distinct gene expression and cell cycle regulatory programs.
- A feedforward programmatic effect of CDK7 inhibitors may lead to hypersensitivity in certain PDAC lines.
- Understanding these differential mechanisms is crucial for developing targeted CDK7-based therapies for pancreatic cancer.
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

